Squamous Cell Carcinoma Mouth
5 clinical trials · Condition
◉ Watch Squamous Cell Carcinoma Mouth
| Record | Firm | Date |
|---|---|---|
| Sitravatinib (MGCD516) and Nivolumab in Oral Cavity Cancer Window Opportunity Study (NCT03575598) | University Health Network, Toronto | 2018-08-30 |
| Pre-operative Mocetinostat (MGCD0103) and Durvalumab (MEDI4736) (PRIMED) for Squamous Cell Carcinoma of the Oral Cavity (NCT02993991) | University Health Network, Toronto | 2017-10-10 |
Track Squamous Cell Carcinoma Mouth automatically
Every clearance here is in the API, with alerts when new ones post.